US4695578A
(en)
*
|
1984-01-25 |
1987-09-22 |
Glaxo Group Limited |
1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
|
EP0191562B1
(de)
*
|
1985-01-23 |
1991-07-10 |
Glaxo Group Limited |
Tetrahydrocarbazolonderivate
|
DE201165T1
(de)
*
|
1985-03-14 |
1989-04-20 |
Beecham Group P.L.C., Brentford, Gb |
Arzneimittel zur behandlung von emesis, anxietas und "irritable bowel syndrome".
|
US5578628A
(en)
*
|
1985-06-25 |
1996-11-26 |
Glaxo Group Limited |
Medicaments for the treatment of nausea and vomiting
|
GB8516083D0
(en)
*
|
1985-06-25 |
1985-07-31 |
Glaxo Group Ltd |
Heterocyclic compounds
|
US5204356A
(en)
*
|
1985-07-24 |
1993-04-20 |
Glaxo Group Limited |
Treatment of anxiety
|
GB8518743D0
(en)
*
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Heterocyclic compounds
|
GB8518658D0
(en)
*
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Medicaments
|
GB8518741D0
(en)
*
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Process
|
GB8518742D0
(en)
*
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Process
|
GB8518745D0
(en)
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Heterocyclic compounds
|
GB8617994D0
(en)
*
|
1986-07-23 |
1986-08-28 |
Glaxo Group Ltd |
Heterocyclic compounds
|
HU202108B
(en)
*
|
1986-07-30 |
1991-02-28 |
Sandoz Ag |
Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
|
AT396870B
(de)
*
|
1986-08-07 |
1993-12-27 |
Sandoz Ag |
Verfahren zur herstellung einer galenischen formulierung zur nasalen verabreichung von serotoninantagonisten
|
GB8623819D0
(en)
*
|
1986-10-03 |
1986-11-05 |
Glaxo Group Ltd |
Heterocyclic compounds
|
GB8627909D0
(en)
*
|
1986-11-21 |
1986-12-31 |
Glaxo Group Ltd |
Medicaments
|
WO1988003801A1
(en)
*
|
1986-11-21 |
1988-06-02 |
Glaxo Group Limited |
Medicaments for treatment or prevention of withdrawal syndrome
|
US5202343A
(en)
*
|
1986-11-28 |
1993-04-13 |
Glaxo Group Limited |
Tricyclic ketones useful as HT3 -receptor antagonists
|
GB8812002D0
(en)
*
|
1988-05-20 |
1988-06-22 |
Glaxo Group Ltd |
Chemical compounds
|
GB8628475D0
(en)
*
|
1986-11-28 |
1987-01-07 |
Glaxo Group Ltd |
Medicaments
|
GR871809B
(en)
*
|
1986-11-28 |
1988-03-07 |
Glaxo Group Ltd |
Process for the preparation of tricyclic ketones
|
GB8630071D0
(en)
*
|
1986-12-17 |
1987-01-28 |
Glaxo Group Ltd |
Medicaments
|
DE3788057T2
(de)
*
|
1986-12-17 |
1994-03-03 |
Glaxo Group Ltd |
Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
|
US5190954A
(en)
*
|
1986-12-17 |
1993-03-02 |
Glaxo Group Limited |
Methods for the treatment of cognitive disorders
|
PH25025A
(en)
*
|
1986-12-17 |
1991-01-28 |
Glaxo Group Ltd |
A method of treating dementia and other cognitive disorders using 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one
|
US5200414A
(en)
*
|
1986-12-17 |
1993-04-06 |
Glaxo Group Limited |
Methods for the treatment of cognitive disorders
|
GB8630079D0
(en)
*
|
1986-12-17 |
1987-01-28 |
Glaxo Group Ltd |
Medicaments
|
US4918080A
(en)
*
|
1987-04-14 |
1990-04-17 |
Glaxo Group Limited |
Imidazollyl containing ketone derivatives
|
EP0295836B1
(de)
*
|
1987-06-16 |
1992-09-02 |
Btg International Limited |
Verwendung von Dioxopiperidin-Derivaten zur Herstellung eines topischen Präparates als Analgetika
|
DE3822792C2
(de)
*
|
1987-07-11 |
1997-11-27 |
Sandoz Ag |
Neue Verwendung von 5HT¶3¶-Antagonisten
|
GB8723157D0
(en)
*
|
1987-10-02 |
1987-11-04 |
Beecham Group Plc |
Compounds
|
JPH01258673A
(ja)
*
|
1987-10-22 |
1989-10-16 |
Glaxo Group Ltd |
ケトン誘導体
|
CA1304082C
(en)
*
|
1987-10-22 |
1992-06-23 |
Tetsuya Tahara |
Benzoxazine compounds and pharmaceutical use thereof
|
US5225431A
(en)
*
|
1987-10-23 |
1993-07-06 |
Burroughs Wellcome Co. |
Therapeutic substituted indole compounds and compositions thereof
|
GB8805269D0
(en)
*
|
1988-03-04 |
1988-04-07 |
Glaxo Group Ltd |
Medicaments
|
JPH0249772A
(ja)
*
|
1988-04-07 |
1990-02-20 |
Glaxo Group Ltd |
イミダゾール誘導体
|
DK185489A
(da)
*
|
1988-04-22 |
1989-10-23 |
Duphar Int Res |
Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
|
US4985422A
(en)
*
|
1988-04-27 |
1991-01-15 |
Glaxo Group Limited |
Lactam derivatives
|
GB8812636D0
(en)
*
|
1988-05-27 |
1988-06-29 |
Glaxo Group Ltd |
Chemical compounds
|
AU627221B2
(en)
*
|
1988-09-27 |
1992-08-20 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyridoindole derivatives and processes for preparation thereof
|
US5173493A
(en)
*
|
1988-09-27 |
1992-12-22 |
Fujisawa Pharmaceutical Company, Ltd. |
Pyridoindole derivatives and processes for preparation thereof
|
US5290785A
(en)
*
|
1988-09-27 |
1994-03-01 |
Fujisawa Pharmaceutical Co., Ltd. |
Therapeutic agent for ischemic diseases
|
FR2639944B1
(fr)
*
|
1988-12-06 |
1991-01-18 |
Adir |
Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
CA2004911A1
(en)
*
|
1988-12-22 |
1990-06-22 |
Mitsuaki Ohta |
4,5,6,7-tetrahydrobenzimidazole derivatives
|
EP0377238A1
(de)
*
|
1988-12-22 |
1990-07-11 |
Duphar International Research B.V |
Annelierte Indolo(3,2-c)-lactame
|
CA2012092A1
(en)
*
|
1989-03-13 |
1990-09-13 |
Tadao Okegawa |
5-ht3 receptor antagonist
|
CA2031214A1
(en)
*
|
1989-04-21 |
1990-10-22 |
Alberto Azcona |
Therapeutic use of 5-ht receptor antagonists
|
GB8914804D0
(en)
*
|
1989-06-28 |
1989-08-16 |
Glaxo Group Ltd |
Process
|
GB8917557D0
(en)
*
|
1989-08-01 |
1989-09-13 |
Glaxo Group Ltd |
Medicaments
|
US5276050A
(en)
*
|
1989-08-01 |
1994-01-04 |
Glaxo Group Limited |
Medicaments
|
US5126343A
(en)
*
|
1989-09-11 |
1992-06-30 |
G. D. Searle & Co. |
N-azabicyclo [3.3.0]octane amides of aromatic acids
|
GB2236751B
(en)
|
1989-10-14 |
1993-04-28 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
GB8928837D0
(en)
*
|
1989-12-21 |
1990-02-28 |
Beecham Group Plc |
Pharmaceuticals
|
US5187166A
(en)
*
|
1990-07-31 |
1993-02-16 |
Nisshin Flour Milling Co., Ltd. |
Azabicyclo derivatives and their use as antiemetics
|
EP1022025A3
(de)
*
|
1991-06-26 |
2002-06-05 |
Sepracor, Inc. |
Verfahren und Zusammensetzungen zur Behandlung von Erbrechen, Übelkeit und anderen Störungen unter Verwendung von optisch reinem S(+)-ondansetron
|
JPH05310732A
(ja)
*
|
1992-03-12 |
1993-11-22 |
Mitsubishi Kasei Corp |
シンノリン−3−カルボン酸誘導体
|
ES2043535B1
(es)
*
|
1992-03-13 |
1994-08-01 |
Vita Invest Sa |
Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
|
HU212934B
(en)
|
1992-10-14 |
1996-12-30 |
Richter Gedeon Vegyeszet |
Process for producing novel alkoxalylated carbazolone derivatives
|
CA2106642C
(en)
*
|
1992-10-14 |
2005-08-16 |
Peter Bod |
Carbazolone derivatives and process for preparing the same
|
CA2157671A1
(en)
*
|
1993-03-08 |
1994-09-15 |
Kiyotaka Katsuta |
Medicament for treating or preventing cerebrovascular diseases
|
GB9310756D0
(en)
*
|
1993-05-25 |
1993-07-14 |
Glaxo Lab Sa |
Compositions
|
GB2325408B
(en)
*
|
1994-06-28 |
1999-01-27 |
Kenneth Francis Prendergast |
Chewing gum formulation comprising ondansetron
|
GB9423588D0
(en)
*
|
1994-11-22 |
1995-01-11 |
Glaxo Wellcome Inc |
Compositions
|
AU702594B2
(en)
*
|
1995-10-13 |
1999-02-25 |
Duphar International Research B.V. |
Process for the preparation of enantiomerically pure imidazolyl compounds
|
US6365743B1
(en)
|
1995-10-13 |
2002-04-02 |
Duphar International Research B.V. |
Process for the preparation of enantiomerically pure imidazolyl compounds
|
US5969137A
(en)
*
|
1996-09-19 |
1999-10-19 |
Virginia Commonwealth University |
Benzylamidine derivatives with serotonin receptor binding activity
|
US6548082B1
(en)
|
1999-03-01 |
2003-04-15 |
Sepracor Inc. |
Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
|
EP1207160A1
(de)
*
|
2000-11-20 |
2002-05-22 |
Hanmi Pharm. Co., Ltd. |
Verfahren zur Herstellung von 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
|
EP1499623B1
(de)
|
2002-04-29 |
2007-06-13 |
TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság |
Verfahren zur herstellung von 1,2,3,9-tetrahydro-9-methyl-3-¬(2-methyl-1h-imidazol-1-yl)methyl|-4h-carbazol-4-on
|
FI6164U1
(fi)
*
|
2003-01-09 |
2004-03-15 |
Synthon Bv |
Ondansetronmuotoja
|
GB2398071B
(en)
*
|
2003-01-24 |
2006-06-07 |
Synthon Bv |
Process for making ondansetron and intermediate thereof
|
ES2238001B1
(es)
*
|
2004-01-21 |
2006-11-01 |
Vita Cientifica, S.L. |
Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
|
US7288660B2
(en)
|
2004-05-07 |
2007-10-30 |
Taro Pharmaceutical Industries Limited |
Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
|
US20090170872A1
(en)
*
|
2005-07-05 |
2009-07-02 |
Orchid Research Laboratories Limited |
Compounds and Their Pharmaceutical Use
|
WO2010133663A1
(en)
|
2009-05-20 |
2010-11-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
|
EP2253316B1
(de)
|
2009-05-20 |
2013-08-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serotonin-5-HT3-Rezeptorantagonisten zur Verwendung bei der Behandlung oder Prävention einer Innenohr-Pathologie mit Vestibularisdefiziten
|
CN115611864A
(zh)
*
|
2022-11-01 |
2023-01-17 |
常州兰陵制药有限公司 |
一种昂丹司琼类化合物及其制备方法与应用
|